Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer Bookmark

Research paper from JAMA Network Open curated by Contributing Editor George Lundberg, MD, who notes: 

This study linked continued opioid use after breast cancer treatment to many serious adverse effects in older women.

.

Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer Bookmark

Research paper from JAMA Oncology curated by Contributing Editor George Lundberg, MD, who notes: 

This study linked coffee consumption with longer survival and lower death rates in advanced colorectal cancer.

.

First Approval of Second-Line Therapy for DLBCL Bookmark

Article from MedPage Today curated by Contributing Editor George Lundberg, MD, who notes: 

The FDA has granted accelerated approval to tafasitamab (brand name Monjuvi) as a second-line therapy for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), based upon overall responses seen in a clinical trial. This is the first FDA approval of a second-line treatment for this condition. There are few, if any, other options.

.

Oral Azacitidine Wins FDA Approval for AML Bookmark

Article from MedPage Today curated by Contributing Editor George Lundberg, MD, who notes: 

The U.S. Food and Drug Administration (FDA) has approved oral azacitidine (brand name Onureg) based on clinical trial results showing a 10-month improvement in overall survival for patients with acute myeloid leukemia who are ineligible for transplant.

.

Raising the Bar for Myelofibrosis Therapy Development Bookmark

Article from MedPage Today curated by Contributing Editor George Lundberg, MD, who notes: 

Myelodysplastic syndrome (MDS) commonly occurs before a patient develops acute leukemia, and is largely unresponsive to therapy. Two new clinical trials are entering phase 3 and may offer some hope.

.

New Pancreatic Cancer Treatment May Add Years to the Lives of Those Facing Death Bookmark

Article from the Miami Herald curated by Contributing Editor George Lundberg, MD, who notes: 

The RenovoCath chemotherapy device permits targeted delivery of usual chemotherapy drugs directly into, and limited to, localized but inoperable pancreatic cancers. It is currently being tested in a phase 3 clinical trial.

.

NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma Bookmark

PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes: 

The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Diffuse Large B-Cell Lymphoma.

.

NCCN Guidelines for Patients: Pediatric ALL Bookmark

PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes: 

The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Pediatric Acute Lymphoblastic Leukemia.

.

NCCN Guidelines for Patients: Kidney Cancer Bookmark

PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes: 

The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Kidney Cancer.

.

NCCN Guidelines for Patients: Liver Cancer Bookmark

PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes: 

The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Liver Cancer.

.

Go to full document published by the NCCN.